Malignant hyperthermia. Update 2000.

N Fortunato-Phillips

Home/Archive/PubMed

PubMed · 11249365

Malignant hyperthermia. Update 2000.

N Fortunato-Phillips

View original source ↗Export metadata ↓

Abstract

MH is a life-threatening crisis that can be controlled if promptly recognized and appropriately treated. Identification of patients at risk for MH is an ongoing crusade. Preparedness with needed supplies available at hand facilitates optimal treatment. All perioperative personnel should remain current in their knowledge of MH management and treatment to ensure the best possible outcome for their patients.

Explore related subjects

Critical Care Humans Malignant Hyperthermia Perioperative Nursing Journal Article Review

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

N Fortunato-Phillips. 2000. Malignant hyperthermia. Update 2000.. https://pubmed.ncbi.nlm.nih.gov/11249365/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2002

The scarred heart: mortality rates for myocardial infarction in the absence of modern therapy.

Explore the source record for details and available documents.

Critical Care↗

PubMed2002

[Critical illness polyneuropathy--a neuromuscular complication in the intensive care patients].

Critical illness polyneuropathy is a serious, but potentially reversible, complication following the treatment of severe infection and respiratory failure in the intensive care unit. A case of prolonged tetraparesis after severe infection and ventilatory support in a middle-aged woman is described.

Critical Care↗

PubMed2002

Position paper of the ESICM Working Group on Nutrition and Metabolism. Metabolic basis of nutrition in intensive care unit patients: ten critical questions.

The metabolic changes associated with critical illness involve several pathways acting at different steps of the utilization of nutritive substrates. The understanding of the role of these pathways and of their complex regulation has led to the development of new strategies for the metabolic and nutritional management of critically ill patients, including the development of new products for nutritional support. The rationale for changing the profile of nutritional support solutions by adding novel substrates is also discussed. This review focuses on the metabolic specificities of critically ill patients and also includes an analysis of the adequacy of tools to monitor the metabolic status and the adequacy of the nutritional support.

Critical Care↗